“ANP has the potential of being a multi billion dollar company...

“ANP has the potential of being a multi billion dollar company if the drug works, the trials go well, and can be financed. “

Thanks dalts66…I’ve said this many times but people don’t seem to share my calls of $5 ( MC under $5 billion)

There has never been any doubt in my mind when ATL1102 proved it could reduce brain lesions in the brain significantly..( applications re Neurodegenerative , Neuromuscular became interesting)That was some 10 yrs ago..
I called Anp another FMG..$$

So here we are today
Atl1102: Commercialisation one study away meeting the same endpoints as our last trial in Aust.
Market for non ambulant $4 billion. But we could also capture the ambulant market as well $$4 billion.
By 2030 combined market $10 billion

Then
We have Limb girdle : Market $4 billion with no treatment Worldwide.

Inflammation market $195 billion( corticosteroid with huge side effects) ATL1102 has proved it reduces inflammation..

Now Long Covid comes into play $$$you

Mac 9
I value your comments
Iv’e read all your posts and get the impression that
you feel the upside is significant if all goes well with DMD trial..?